First published 10/2/2026, 1:57:15 AM · Last updated 10/2/2026, 1:57:15 AM

Exploring molecular mechanisms of thromboxane synthase inhibition in osteoblast differentiation and mineralization, and the pathophysiology of the IFITM5 pathogenic variant in osteogenesis imperfecta type V

A dissertation investigating how thromboxane synthase inhibition affects osteoblast differentiation and mineralization and examining the pathophysiology of the IFITM5 pathogenic variant in osteogenesis imperfecta type V. Published by Agence Bibliographique de l'Enseignement Supérieur on 2026-04-09.

Categories: science-and-space, public-health, positive-progress

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 7/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The work addresses molecular mechanisms related to a genetic bone disorder (osteogenesis imperfecta type V).

Sources

Exploring molecular mechanisms of thromboxane synthase inhibition in osteoblast differentiation and mineralization, and the pathophysiology of the IFITM5 pathogenic variant in osteogenesis imperfecta type V

Report an issue